Gastroenterology

The researchers discussed the use of risankizumab induction therapy and its ability to treat symptoms that greatly affect the lives of patients with Crohn disease. The research was presented at ACG 2022. ...

After 30 years, new guidelines and recommendations have been issued regarding metabolic and bariatric surgery, providing updated guidance for clinicians to follow.

According to a recent study, subcutaneous maintenance dosing of risankizumab at 52 weeks is effective and well-tolerated in patients with moderate-to-severe Crohn disease who had a delayed response to...

The researchers sought to compare the relative efficacy and safety of biologics and small molecule drugs for the treatment of patients with moderate-to-severe ulcerative colitis.

Researchers conducted a systematic review and meta-analysis to evaluate the efficacy and safety of fecal microbiota transplantation as a treatment for ulcerative colitis.

The American Gastroenterological Association has updated its guidelines on the management of irritable bowel syndrome with diarrhea.

Researchers examined the presence of undiagnosed severe exocrine pancreatic insufficiency in individuals with irritable bowel syndrome plus diarrhea, as well as the associated symptoms and the impact of...

Researchers examined the prevalence of esophageal cancer and Barrett esophagus in US adults.

In a recent study, researchers examined how the frequency and type of antibiotics used may impact the gut microbiota and the subsequent risk of colorectal cancer in patients taking antibiotics.

The American Society of Colon and Rectal Surgeons has updated its guidelines on colonic volvulus and acute colonic pseudo-obstruction.